Skip to search formSkip to main contentSkip to account menu

OK-432

Known as: Streptococcal OK 432, Streptococcal OK432, 432 ok 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2008
Review
2008
Abstract Objective: We report an adult case of cystic lymphangioma treated with OK-432 (Picibanil®). Method: A case report and… 
2006
2006
OK-432 is a Streptococcus-derived immunotherapeutic agent for malignancies. Our group has tried to identify the effective… 
1997
1997
The effect of local injections with streptococcal preparation OK432 on the therapeutical potential of tumor‐draining lymph node… 
1994
1994
Among head and neck angiotumors, cystic lymphangioma occurs in infancy in most cases and it is rare in adulthood. Plunging ranula… 
1991
1991
The radioprotective effect of OK432, a Streptococcus haemolyticus preparation, on bone marrow death was examined in mice. The… 
1987
1987
A streptococcal preparation, OK-432, was employed as the adjuvant immunotherapeutic agent combined with chemotherapy in cases of… 
1986
1986
produced IL-2 when the cells were obtained from mice presensitized with OK-432. They also described a lymphokine, distinct from… 
1981
1981
In vivo effect of an immunostimulant, OK-432, on hematopoietic spleen colonies (CFU-S) was investigated in irradiated JCL/ICR… 
1979
1979
Candida albicans is known to be one of the major causative agents of opportunistic infection. It is well known that patients with… 
1976
1976
An inactivated and lyophilized preparation of a low virulence strain (Su) of Streptococcus pyogenes (group A) was designated OK…